Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page
- Check7 days agoChange DetectedDifference0.3%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.6%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedDifference0.3%
- Check43 days agoChange DetectedDifference0.2%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.